Velásquez G
Département de Coopération technique pour les médicaments essentiels et la médecine traditionnelle, l'Organisation mondiale de la santé, Genève, Suisse.
Med Trop (Mars). 2006 Dec;66(6):526-8.
The agreement on trade-related aspects of intellectual property rights (trips) was established in 1994 simultaneously with the founding of the world trade organization (wto). the TRIPS agreement requires all WTO member states to grant patent protection for pharmaceutical products or processes for a period of at least 20 years. However only a few of the hundreds of pharmaceutical products patented every year involve new molecules. It is increasingly urgent to enhance the transparency and efficiency of the patenting process for pharmaceutical products. It is especially important for developing countries to increase scrutiny of how patents are processed and granted. This is necessary to prevent the detrimental effects of patenting of non-innovative products on access to medicines.
《与贸易有关的知识产权协定》（TRIPS）于1994年与世界贸易组织（WTO）的成立同时确立。TRIPS协定要求所有世贸组织成员国为药品或制药工艺提供至少20年的专利保护。然而，每年获得专利的数百种药品中只有少数涉及新分子。提高药品专利申请程序的透明度和效率变得越来越紧迫。对发展中国家而言，加强对专利审批过程的审查尤为重要。这对于防止非创新产品专利对药品可及性产生不利影响是必要的。
